... the influence of other patient characteristics (e.g., age, gender, smoking status, medication use) on the ability of the biomarker to discriminate between those with and without preclinical disease. Phase 4 — Prospective screening studies Determine the operating characteristics ...

... Yusuke, Inuzuka, Ryo, Harita, Yutaka et al. (2013) Age-related differences in the course of the acute phase symptoms of Kawasaki disease. The Pediatric infectious disease journal 32(9): e365– ...

... After Initial Treatment With Autologous HCT In a phase II study, patients (median age, 26.5 years) who had relapsed or refractory disease after autologous HCT received brentuximab vedotin, with an ...

... Most EPC authors considered demographic variables such as age, sex, race, and ... the protocol development phase (a priori); several consult with experts in the ...

... EFS for 96 patients with osteosarcoma and measurable disease was 12% at 4 ... ethnicity. One additional phase II trial with a different study design was ...

... the different capacity for work productivity during different phases of life. DALYs are therefore estimated for different chronic illnesses by first calculating the age- and sex-adjusted incidence of disease. A DALY is calculated as the sum of ...

... 40 countries. Among individuals with early-onset disease (age <50 years), ... a Phase III clinical trial for ATTR cardiomyopathy including hereditary ...

... not commonly be expected during the usual childbearing age ... and acute phase reactivity, molecules to block polymer formation, and gene ...

... who have become very frail due to old age and possible chronic diseases such as ... the final phase of life easier and to consider individual preferences ...